APA (7th ed.) Citation

Ou, Z., Nohria, A., Spring, L., Seeger, J., Doucette, J., & Murimi-Worstell, I. (2022). SA33 Real-World Cardiac Safety of Anti-HER2 Therapies in Elderly Patients with HER2+/HR-Metastatic Breast Cancer: A Retrospective Cohort Study Using SEER-Medicare DATA 2012-2016. Value in Health, 25(7), S610. https://doi.org/10.1016/j.jval.2022.04.1699

Chicago Style (17th ed.) Citation

Ou, Z., A. Nohria, LM Spring, JD Seeger, J. Doucette, and IB Murimi-Worstell. "SA33 Real-World Cardiac Safety of Anti-HER2 Therapies in Elderly Patients with HER2+/HR-Metastatic Breast Cancer: A Retrospective Cohort Study Using SEER-Medicare DATA 2012-2016." Value in Health 25, no. 7 (2022): S610. https://doi.org/10.1016/j.jval.2022.04.1699.

MLA (9th ed.) Citation

Ou, Z., et al. "SA33 Real-World Cardiac Safety of Anti-HER2 Therapies in Elderly Patients with HER2+/HR-Metastatic Breast Cancer: A Retrospective Cohort Study Using SEER-Medicare DATA 2012-2016." Value in Health, vol. 25, no. 7, 2022, p. S610, https://doi.org/10.1016/j.jval.2022.04.1699.